Mawdsleys are a global pharmaceutical service provider offering a wide range of services to the pharmaceutical industry and healthcare sector.

For nearly 200 years, our commitment to excellence and high service levels has gained us our reputation as leading partner to the industry and healthcare sector. Read more about us...

Who we help

PHARMACEUTICAL &
BIOTECH COMPANIES

UK PRIMARY
CARE

UK SECONDARY
CARE

GLOBAL HEALTHCARE
PROFESSIONALS

Our Specialist Solutions

NAMED PATIENT
MEDICINES

MARKET ACCESS
SOLUTIONS

THIRD PARTY
LOGISTICS

For more information call
+44 (0)844 736 9016
or email us here

Tweets by @MawdsleysUK

Mawdsleys Online

Latest News

Oct 2, 2018

Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher® (Nimotuzumab) in the UK and Ireland

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer.

Customer Testimonials

UK Primary Care
UK Secondary Care
Pharma Clients
Manufacturers
International Clients

Subscribe to our Mailing List

Helping ensure patients have access to the drugs they need, when they need them.